Immediate Impact

2 from Science/Nature 61 standout
Sub-graph 1 of 23

Citing Papers

Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
2024 Standout
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
1 intermediate paper

Works of Verena Karsten being referenced

A PHASE 2, MULTI-CENTER, OPEN-LABEL TRIAL TO EVALUATE THE SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS AND EXPLORATORY CLINICAL ACTIVITY OF ALN-TTRSC, AN RNAI THERAPEUTIC FOR THE TREATMENT OF PATIENTS WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS
2015

Author Peers

Author Last Decade Papers Cites
Verena Karsten 157 109 97 136 124 19 402
Arunima Mukhopadhyay 189 90 138 30 150 18 445
Fabien Sindikubwabo 198 28 60 169 132 10 450
Christine Adhiambo 116 16 244 70 64 14 437
Sirenia González 74 28 46 142 110 15 372
Xufeng Luo 217 90 16 50 72 17 414
Tânia Cruz 146 18 207 43 119 18 438
Kyle Bauckman 164 62 37 18 157 17 420
Carole Serveau 188 25 192 36 214 13 412
Ameya Sinha 205 17 128 43 36 16 410
Zhenping Ming 150 23 27 150 61 20 406

All Works

Loading papers...

Rankless by CCL
2026